Newsfeeds Archive - Spark Newswire

1 minute read

Sight Sciences Announces The Publication Of Large-Scale, Real-World MIGS Study Demonstrating The Aqueous Outflow Restorative Procedure With OMNI Surgical System Technology Is Effective At Lowering Both IOP And IOP Reducing Medications At 2 Years In Pat…

April 10, 4:08 PM

Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and

SGHT

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

April 2, 4:31 PM

Gainers OneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday’s after-market session. The market value of…

ACOR

3 minute read

Sight Sciences Announces The Results Of The 3-Year Prospective GEMINI Trial And The Cross-Over Phase Of The SAHARA RCT At The 2024 American Society Of Cataract And Refractive Surgery Annual Meeting

By Benzinga Newsdesk

April 2, 4:13 PM

Clinical results demonstrate long-term efficacy of the OMNI® Surgical System for primary open-angle glaucoma and support use of TearCare® technology as a primary treatment for dry eye disease. MENLO PARK,

SGHT

2 minute read

Global
News

Sight Sciences Announces European Launch Of The Ergo-Series Of The OMNI Surgical System At The ESCRS Winter Meeting

By Benzinga Newsdesk

February 14, 5:37 PM

SGHT

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

January 24, 1:31 PM

Gainers Kura Oncology (NASDAQ:KURA) stock rose 48.1% to $19.87 during Wednesday’s regular session. The market value of their…

ANVS

2 minute read

Sight Sciences Announces Withdrawal Of Final LCDs On Micro-Invasive Glaucoma Surgery From Five Medicare Administrative Contractors That Were Scheduled To Take Effect On January 29, 2024.

By Benzinga Newsdesk

December 28, 10:16 AM

Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, supports the

SGHT

4 minute read

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

December 26, 2:48 PM

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.

AAOI